Exploitation of the Toll-like receptor system in cancer: a doubled-edged sword? - Test2 - elhamkhani - TriplyDB

Exploitation of the Toll-like receptor system in cancer: a doubled-edged sword?

Exploitation of the Toll-like receptor system in cancer: a doubled-edged sword?

http://www.wikidata.org/entity/Q36557953

about

Toll-like Receptors in Ovarian Cancer as Targets for Immunotherapies Early experience with novel immunomodulators for cancer treatment No genetic relationship between TLR2 rs4696480, rs3804100, and rs3804099 gene polymorphisms and female breast cancer in Saudi populations.High expression of Toll-like receptor 4/myeloid differentiation factor 88 signals correlates with poor prognosis in colorectal cancer.Non-invasive imaging of Toll-like receptor 5 expression using (131)I-labeled mAb in the mice bearing H22 tumors Triggering of TLR7 and TLR8 expressed by human lung cancer cells induces cell survival and chemoresistance.Peroxiredoxin 1 stimulates secretion of proinflammatory cytokines by binding to TLR4 Toll-like receptors and cancer, particularly oral squamous cell carcinoma.A synthetic dsRNA, as a TLR3 pathwaysynergist, combined with sorafenib suppresses HCC in vitro and in vivo.Inherited variation in pattern recognition receptors and cancer: dangerous liaisons?Alterations in ubiquitin ligase Siah-2 and its corepressor N-CoR after P-MAPA immunotherapy and anti-androgen therapy: new therapeutic opportunities for non-muscle invasive bladder cancer.Toll-like receptors as novel therapeutic targets for ovarian cancer.Increased toll-like receptors and p53 levels regulate apoptosis and angiogenesis in non-muscle invasive bladder cancer: mechanism of action of P-MAPA biological response modifier.Effects of P-MAPA Immunomodulator on Toll-Like Receptors and p53: Potential Therapeutic Strategies for Infectious Diseases and Cancer Prognostic significance of MyD88 expression by human epithelial ovarian carcinoma cells.Protective role of Toll-like receptor 4 during the initiation stage of cutaneous chemical carcinogenesis.Application potential of toll-like receptors in cancer immunotherapy: Systematic review.Network analysis reveals functional cross-links between disease and inflammation genes.Significance of toll-like receptors expression in tumor growth and spreading: a short review Atractylenolide-I sensitizes human ovarian cancer cells to paclitaxel by blocking activation of TLR4/MyD88-dependent pathway.Fueling inflammation at tumor microenvironment: the role of multiligand/RAGE axis.Tumor microenvironment is multifaceted.Association between Toll-like receptor 3 polymorphisms and cancer risk: a meta-analysis.Immunohistochemical expression of TLR4 and TLR9 in various grades of oral epithelial dysplasia and squamous cell carcinoma, and their roles in tumor progression: a pilot study.Poly I:C inhibits cell proliferation and enhances the growth inhibitory effect of paclitaxel in oral squamous cell carcinoma.Development of monoclonal antibodies that specifically interact with necrotic lymphoma cells.Toll-like receptor agonists induce inflammation and cell death in a model of head and neck squamous cell carcinomas.Tumor immunotherapy using bone marrow-derived dendritic cells overexpressing Toll-like receptor adaptors.A new role for microRNAs, as ligands of Toll-like receptors.Editorial: Pattern Recognition Receptors and Cancer Decreased expression of TLR7 in gastric cancer tissues and the effects of TLR7 activation on gastric cancer cells.Toll-like receptor 2 is present in the microenvironment of oral squamous cell carcinoma.Type I IFN innate immune response to adenovirus-mediated IFN-gamma gene transfer contributes to the regression of cutaneous lymphomas Significant correlation of TLR4 expression with the clinicopathological features of invasive ductal carcinoma of the breast.High mobility group box 1/toll-like receptor 4/myeloid differentiation factor 88 signaling promotes progression of gastric cancer.The Role of Toll-Like Receptor in Inflammation and Tumor Immunity

P2860

Q26861234-B070D83C-B7AD-49CE-8DB8-B92CEA27EB3C Q28241744-916C5663-AB23-4B8C-8676-52F68B4D4DE4 Q33632400-9B91970C-9555-48B0-A4D7-24132E268E39 Q33708134-F2AC2F44-19D5-42A1-835A-D16E7C28C3B2 Q33727715-A546B51A-226A-40F6-921E-2B4D7A7C77A3 Q33755300-9C175168-D276-4517-975F-9487647342EC Q34204503-D543C7FE-B629-4613-9A9B-720AB5A6E927 Q34239239-E2AC46BE-D647-47D1-8173-84D5E59BF77B Q35032965-25157FE4-8161-4DFE-87DF-BC94365C3844 Q35832150-2101FB30-EFE2-4422-AF01-9A1CA2088F6B Q35853865-A2A08BE6-C0B2-45D1-A34C-DF8FDF57FA60 Q35864309-9FABFFE5-038F-42ED-B856-F5929E8B4780 Q36070462-E780EAAF-E610-4FE6-A69A-32990597C1D6 Q36127825-BE541447-2ADF-4AF5-8B05-53EA5A309836 Q36222691-E793D1DA-B923-49C4-9A17-ECA3FEC5982E Q36600103-8BBDA4CD-0A1D-4F36-A9FF-CB2C3BBBE3BA Q37205171-0070B1FC-36FB-4885-B479-B1DADE38C5A7 Q37365610-B92CF1BA-1126-4E2A-BE89-2221F51C8E81 Q37421540-2CC7BAAA-C7AD-40FD-96B6-9E5421607F97 Q37506796-5A30F21E-B195-4961-8C8E-F27B97BA8F3F Q37661169-D3065B9F-4147-4B4F-9F8C-C9C1DFE308B5 Q37832693-A1D318AB-DFB6-4232-9C5E-CF157356DEFB Q38398013-4FA974B9-F7B7-4AC7-A6E8-4F09E9D7E347 Q39423531-DABC7342-A566-4279-820A-F6BE4D44049E Q39425739-2DE0E7E8-A58A-4F77-8D74-39A5BB8295C0 Q39553511-F265FF48-FAE2-4CF3-8FD9-7135A7185AB7 Q39796172-0FAD1B35-A44F-46E1-A20B-B811330F07C5 Q40113595-253AF301-ED1F-423B-8273-4BA034590132 Q41295458-A3230FF3-435A-4BA5-8843-55AAE8AEC080 Q42093241-5E074EAD-C22B-43A8-9896-76FD47F60F1D Q42109641-D9F37B02-30D0-49B5-9AE4-F18AA331F58A Q42276876-6722F1B6-C0E9-4412-ABD5-78C4013A29FD Q42397243-6B13F280-CACF-40CD-AB57-1591F91F475D Q44147242-D777EFAF-562D-4D91-AC8F-C2585D8C074A Q51083811-3717249F-E0D9-458B-AAEB-E35A9097B2BB Q57170572-158C8BCD-832A-40A2-82FF-E1EC5843754C

P2860

Exploitation of the Toll-like receptor system in cancer: a doubled-edged sword?

http://www.wikidata.org/entity/Q36557953

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

2006年论文

@zh

2006年论文

@zh-cn

name

Exploitation of the Toll-like receptor system in cancer: a doubled-edged sword?

@ast

Exploitation of the Toll-like receptor system in cancer: a doubled-edged sword?

@en

type

label

Exploitation of the Toll-like receptor system in cancer: a doubled-edged sword?

@ast

Exploitation of the Toll-like receptor system in cancer: a doubled-edged sword?

@en

prefLabel

Exploitation of the Toll-like receptor system in cancer: a doubled-edged sword?

@ast

Exploitation of the Toll-like receptor system in cancer: a doubled-edged sword?

@en

P1433

Q36557953-F6E7CDB2-830D-426B-B4D5-C65D593E941D

P1476

Q36557953-DD2D2656-F722-4CED-9564-F8BA98FFB70D

P2093

Q36557953-809703A1-351A-4303-BCB3-423B9BDFB059

Q36557953-9258764D-873F-4D3E-BEE3-E2AD42CBB952

Q36557953-B33522BB-4EA6-4257-AD45-EA6F09B9C623

Q36557953-D9EF0E4A-4B62-406F-BB4A-46C25CA97108

P2860

Q36557953-03A83425-A870-430C-B6C8-86445D5B4FC0

Q36557953-10B22468-C39E-4C11-860D-A90936D68273

Q36557953-1AC545CB-9BD2-47B3-B5ED-05D4F2B7EABE

Q36557953-1EDEB17B-44AB-4B85-92F5-0BFA91F21D14

Q36557953-243BA9EC-41AC-407A-800E-9AC39DFB3DDB

Q36557953-34FB65D1-3B04-43A5-959B-D369B82FCA95

Q36557953-3686327F-0A8F-42DD-8FF0-DEC7C33E04D5

Q36557953-36BD030D-DAB7-4208-B74D-BB2DB7266838

Q36557953-41392517-2620-421E-BFE6-089BAFB8F513

Q36557953-48A45CA0-CCB8-4186-9C93-772169C4FB94

P2888

Q36557953-3830E040-270D-4C62-A7DC-A78D24E804BE

P304

Q36557953-6E71D4DB-70DA-45D8-A176-5E211A02586A

P31

Q36557953-3FA1ACB9-E1E0-4EF2-A610-3B89A062A072

Q36557953-F0CFD54A-65BA-4DD4-AE81-B2D914B8180F

P356

Q36557953-1809B801-45D8-4FF2-A83B-97AB9D0C964F

P407

Q36557953-3442C1AC-38D1-40F2-B865-13157C525970

P433

Q36557953-B3F3E430-A682-4D25-8F84-0982755D8168

P478

Q36557953-20C1CA5D-1E20-447A-B3DC-307EB84913D2

P577

Q36557953-6FA86CE5-AA73-480F-9B2D-D9C802F6FF8A

Q36557953-E962AE30-55FE-4F15-9883-45A0F9A2BBA2

P5875

Q36557953-12B4F280-CAB8-4EC8-87FB-1480C45C7031

P698

Q36557953-382F486A-66F2-4F37-9935-F286007F334F

P921

Q36557953-44CA0EC2-86AD-42F2-B11B-E7FAF5300F4E

Q36557953-769D75CD-5C30-4679-9C27-3DFCE86CF5CE

Q36557953-9CE17170-B5F1-4AC5-860C-6970A8E77AC2

Q36557953-A02B8F1B-19A1-45BB-AC38-511595B326D6

Q36557953-BD977E65-6874-433D-8F55-D4C373C553B8

P932

Q36557953-372F2EAF-A062-4EEF-8B6E-088170007519

P356

P1433

British Journal of Cancer

P1476

Exploitation of the Toll-like receptor system in cancer: a doubled-edged sword?

@en

P2093

E J Andrews

http://www.w3.org/2001/XMLSchema#string

H P Redmond

http://www.w3.org/2001/XMLSchema#string

J H Wang

http://www.w3.org/2001/XMLSchema#string

S D Killeen

http://www.w3.org/2001/XMLSchema#string

P2860

Tumor cells deactivate human monocytes by up-regulating IL-1 receptor associated kinase-M expression via CD44 and TLR4

Toll-like receptor 8-mediated reversal of CD4+ regulatory T cell function

Inflammation and cancer

Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis

IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer

Addicted to death: invasive cancer and the immune response to unscheduled cell death.

Bugs as drugs for cancer.

Assay of locus-specific genetic load implicates rare Toll-like receptor 4 mutations in meningococcal susceptibility

Inherited disorders of NF-kappaB-mediated immunity in man.

Endogenous ligands of Toll-like receptors.

P2888

P304

247-252

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SJ.BJC.6603275

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

95

http://www.w3.org/2001/XMLSchema#string

P577

2006-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

2006-08-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6895098

http://www.w3.org/2001/XMLSchema#string

P698

16892041

http://www.w3.org/2001/XMLSchema#string

P921

cell surface receptor

Toll-like receptor

pattern recognition receptors

membrane proteins

P932

2360630

http://www.w3.org/2001/XMLSchema#string